MedPath
NMPA Approval

Ixazomib Citrate Capsules

国药准字H20253310

January 24, 2025

Drug Information

枸橼酸伊沙佐米胶囊

胶囊剂

2.3mg(按C₁₄H₁₉BCl₂N₂O₄计)

化学药品

January 24, 2025

Company Information

Applicant Company

山东省济南市高新区新泺大街317号

Manufacturing Company

山东省济南市高新区旅游路8888号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

枸橼酸伊沙佐米胶囊 - NMPA 批准文号 | MedPath